Nora Isberner

Oberdürrbacher Str. 6
Wuerzburg, BY 97080, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple Myeloma.

Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for Multiple Myeloma.

Journal: Blood advances

Published: August 11, 2025

Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for multiple myeloma.

Significant burden of low-grade infections in patients treated with T-cell-engaging therapies for multiple myeloma.

Journal: Blood advances

Published: August 11, 2025

Increasing Relevance.

Increasing Relevance.

Journal: Deutsches Arzteblatt international

Published: July 22, 2025

Model-based assessment of letermovir pharmacokinetics in allogeneic haematopoietic stem cell transplant recipients.

Model-based assessment of letermovir pharmacokinetics in allogeneic haematopoietic stem cell transplant recipients.

Journal: The Journal of antimicrobial chemotherapy

Published: May 06, 2025

Fever of unknown origin in B-cell depleted patients: Have you considered Neoehrlichiosis?

Fever of unknown origin in B-cell depleted patients: Have you considered Neoehrlichiosis?

Journal: Clinical rheumatology

Published: January 15, 2025

Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib.

Clinical validation and assessment of feasibility of volumetric absorptive microsampling (VAMS) for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib, and ruxolitinib.

Journal: Journal of pharmaceutical and biomedical analysis

Published: December 23, 2022

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients.

A Physiologically-Based Pharmacokinetic Model of Ruxolitinib and Posaconazole to Predict CYP3A4-Mediated Drug-Drug Interaction Frequently Observed in Graft versus Host Disease Patients.

Journal: Pharmaceutics

Published: October 24, 2022

Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma.

Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma.

Journal: Cancers

Published: August 04, 2022

Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort.

Convalescent plasma treatment for SARS-CoV-2 infected high-risk patients: a matched pair analysis to the LEOSS cohort.

Journal: Scientific reports

Published: February 21, 2022

COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.

COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.

Journal: United European gastroenterology journal

Published: January 17, 2022

Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.

Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.

Journal: Clinical biochemistry

Published: December 27, 2021

Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry.

Hospitalized patients dying with SARS-CoV-2 infection-An analysis of patient characteristics and management in ICU and general ward of the LEOSS registry.

Journal: PloS one

Published: October 08, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026